Maria Fardis
CIK 1559231 · President and CEO · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.22M
Companies
3
Total Filings
30
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 3
30 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-02-05 | IOVA | Tax (F) | −1,302 | -$29.3K | EDGAR |
| 2020-01-07 | IOVA | Grant (A) | — | $0 | EDGAR |
| 2020-01-06 | IOVA | Tax (F) | −1,562 | -$41.7K | EDGAR |
| 2019-12-04 | IOVA | Tax (F) | −237,959 | -$1.69M | EDGAR |
| 2019-12-04 | IOVA | Tax (F) | −3,788 | -$84.5K | EDGAR |
| 2019-03-06 | IOVA | Grant (A) | — | $0 | EDGAR |
| 2018-02-12 | IOVA | Grant (A) | — | $0 | EDGAR |
| 2016-08-19 | IOVANCE BIOTHERAPEUTICS, INC. (LBIO) Delisted | Other (J) | — | $0 | EDGAR |
| 2016-08-18 | IOVANCE BIOTHERAPEUTICS, INC. (LBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-09 | IOVANCE BIOTHERAPEUTICS, INC. (LBIO) Delisted | Grant (A) | +550,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.